These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35602649)

  • 21. Progression of regional grey matter atrophy in multiple sclerosis.
    Eshaghi A; Marinescu RV; Young AL; Firth NC; Prados F; Jorge Cardoso M; Tur C; De Angelis F; Cawley N; Brownlee WJ; De Stefano N; Laura Stromillo M; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Geurts JJG; Vrenken H; Wottschel V; Leurs CE; Uitdehaag B; Pirpamer L; Enzinger C; Ourselin S; Gandini Wheeler-Kingshott CA; Chard D; Thompson AJ; Barkhof F; Alexander DC; Ciccarelli O
    Brain; 2018 Jun; 141(6):1665-1677. PubMed ID: 29741648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant.
    Gatto RG; Martin PR; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Dickson DW; Josephs KA; Whitwell JL
    Neuroimage Clin; 2022; 35():103030. PubMed ID: 35597031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy - A double-validation whole-brain meta-analysis.
    Albrecht F; Bisenius S; Neumann J; Whitwell J; Schroeter ML
    Neuroimage Clin; 2019; 22():101722. PubMed ID: 30831462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsy.
    Paviour DC; Schott JM; Stevens JM; Revesz T; Holton JL; Rossor MN; Lees AJ; Fox NC
    J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1772-5. PubMed ID: 15548504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [An 81-year-old woman with progressive motor disturbance, extrapyramidal features, dementia, and oculomotor palsy].
    Urabe T; Mori H; Sumino S; Miwa H; Wakiya M; Shirai T; Takubo H; Mizuno Y
    No To Shinkei; 1998 Mar; 50(3):291-301. PubMed ID: 9566008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Social cognitive deficits and their neural correlates in progressive supranuclear palsy.
    Ghosh BC; Calder AJ; Peers PV; Lawrence AD; Acosta-Cabronero J; Pereira JM; Hodges JR; Rowe JB
    Brain; 2012 Jul; 135(Pt 7):2089-102. PubMed ID: 22637582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study.
    Miki Y; Foti SC; Asi YT; Tsushima E; Quinn N; Ling H; Holton JL
    Brain; 2019 Sep; 142(9):2813-2827. PubMed ID: 31289815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
    Lehéricy S; Hartmann A; Lannuzel A; Galanaud D; Delmaire C; Bienaimée MJ; Jodoin N; Roze E; Gaymard B; Vidailhet M
    Brain; 2010 Aug; 133(Pt 8):2410-25. PubMed ID: 20826434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evolution of primary progressive apraxia of speech.
    Josephs KA; Duffy JR; Strand EA; Machulda MM; Senjem ML; Gunter JL; Schwarz CG; Reid RI; Spychalla AJ; Lowe VJ; Jack CR; Whitwell JL
    Brain; 2014 Oct; 137(Pt 10):2783-95. PubMed ID: 25113789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy.
    Reginold W; Lang AE; Marras C; Heyn C; Alharbi M; Mikulis DJ
    Parkinsonism Relat Disord; 2014 Feb; 20(2):222-5. PubMed ID: 24239142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy.
    Choi JH; Kim H; Shin JH; Lee JY; Kim HJ; Kim JM; Jeon B
    J Neurol; 2021 Mar; 268(3):967-977. PubMed ID: 32959131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report].
    Morishima R; Bandoh M; Sunami Y; Isozaki E
    Rinsho Shinkeigaku; 2019 Nov; 59(11):730-735. PubMed ID: 31656263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement.
    Iwasaki Y; Mori K; Ito M; Tatsumi S; Mimuro M; Yoshida M
    Neuropathology; 2013 Oct; 33(5):561-7. PubMed ID: 23320789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progressive supranuclear palsy: a clinical, natural history and disability study].
    Macia F; Ballan G; Yekhlef F; Delmer O; Vital C; Lagueny A; Tison F
    Rev Neurol (Paris); 2003 Jan; 159(1):31-42. PubMed ID: 12618651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methods and utility of quantitative brainstem measurements in progressive supranuclear palsy versus Parkinson's disease in a routine clinical setting.
    Cooperrider J; Bluett B; Jones SE
    Clin Park Relat Disord; 2020; 3():100033. PubMed ID: 34316619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Progressive Supranuclear Palsy Clinical Deficits Scale.
    Piot I; Schweyer K; Respondek G; Stamelou M; ; ; ; Sckopke P; Schenk T; Goetz CG; Stebbins GT; Höglinger GU
    Mov Disord; 2020 Apr; 35(4):650-661. PubMed ID: 31951049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
    Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy.
    Ghosh BC; Carpenter RH; Rowe JB
    PLoS One; 2013; 8(9):e74486. PubMed ID: 24058574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
    Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
    Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.